Neuroscience-focused digital technology company Ixico just nabbed a contract for imaging clinical trial services from Spanish biotech Araclon.

Science Exchange has raised $28 million in its third funding round.

INC says it is focused on growing its Asia presence with moves and an expansion.

Parexel has become the latest CRO to be bought up as the industry continues its M&A bonanza.

Probably hoping to help turn things around after clinical setbacks, microRNA biotech Regulus tapped the help of CRO Aptuit.

Eisai and partner Charles River have clearly enjoyed their two-year R&D deal, as the pharma-CRO pair have signed up to extend that partnership for another…

Charles River Laboratories has beefed up its library of patient-derived xenografts (PDXs) by adding new genetic characteristics into the mix.

DelMar is advancing its first-in-class brain cancer med dianhydrogalactitol (VAL-083) into phase 3, and it has recruited PRA Health Sciences to conduct that…

CRO Clinigen is teaming up with biotech Tesaro and its PARP ovarian cancer med niraparib to help launch an early access program in Europe, coming after the…

R&D